Effects of metrifonate on radial arm maze acquisition in middle-aged rats

Brain Research

Volumn 777, Issue 1-2, 1997, Pages 251-254

  Dachir, Shlomit ^a   Schmidt, Bernard ^b   Levy, Aharon ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

^b CNS Research   (Germany)

Author keywords

Aging; Alzheimer's disease; Cholinesterase inhibitor; Corticosterone

Indexed keywords

CHOLINESTERASE INHIBITOR; CORTICOSTERONE; METRIFONATE;

AGING; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; MALE; MAZE TEST; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPATIAL ORIENTATION; SUBCUTANEOUS DRUG ADMINISTRATION; TASK PERFORMANCE;

AGE FACTORS; AGING; ANIMALS; ANTI-INFLAMMATORY AGENTS; CEREBRAL CORTEX; CHOLINESTERASE INHIBITORS; CORTICOSTERONE; HIPPOCAMPUS; MALE; MAZE LEARNING; RATS; RATS, INBRED F344; TRICHLORFON;

EID: 0031589712     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01234-1     Document Type: Article

References (25)

1. [1] I. Arbel, T. Kadar, M. Silberman, A. Levy, The effects of long-term corticosterone administration on hippocampal morphology and cognitive performance of middle-aged rats, Brain Res. 657 (1994) 235-237.
2. [2] M.H. Bassant, F. Jazat-Poindessous, Y. Lamour, Effects of metrifonate, a cholinesterase inhibitor, on local cerebral glucose utilization in young and aged rats, J. Cerebral Blood Flow Metab. 16 (1996) 1014-1025.
3. [3] M. Bjorklund, P. Jakala, B. Schmidt, M. Riekkinen, E. Koivisto, P. Riekkinen Jr., An indirect cholinesterase inhibitor, metrifonate, increases neocortical EEG arousal in rats, NeuroReport 7 (1996) 1097-1101.
4. [4] A. Blokland, V. Hinz, B.H. Schmidt, Effects of metrifonate and tacrine in the spatial Morris task and modified Irwin test: evaluation of the efficacy/safety profile in rats, Drug Dev. Res. 36 (1995) 166-179.
5. [5] R. Brandeis, S. Dachir, M. Sapir, A. Levy, A. Fisher, Reversal of age-related cognitive impairments by an M1 cholinergic agonist, AF102B, Pharmcol. Biochem. Behav. 36 (1990) 89-95.
6. [6] J. Cummings, F. Bieber, J. Mas, J. Orazem, B. Gulanski, Metrifonate in Alzheimer's disease - results of a dose-finding study, Neurobiol. Aging 17 (4S) (1996) S153-S154.
7. [7] S. Dachir, T. Kadar, B. Robinzon, A. Levy, Cognitive deficits induced in young rats by long-term corticosterone administration, Behav. Neural Biol. 60 (1993) 103-109.
8. [8] S. Dachir, T. Kadar, B. Robinzon, A. Levy, Nimodipine's protection against corticosterone-induced morphological changes in the hippocampus of young rats, Brain Res. 748 (1997) 175-183.
9. [9] T. Kadar, M. Silbermann, R. Brandeis, A. Levy, Age-related structural changes in the hippocampus: correlation with working memory deficiency, Brain Res. 512 (1990) 113-120.
10. [10] A. Levy, R. Brandeis, T.A. Treves, Y. Meshulam, F. Mawassi, D. Feiler, A. Wengier, P. Glikfeld, J. Grunwald, S. Dachir, J.M. Rabey, D. Levy, A.D. Korczyn, Transdermal physostigmine in the treatment of Alzheimer's disease, Alzheimer Disease and Associated Disorders 8 (1994) 15-21.
11. [11] A. Levy, S. Dachir, I. Arbel, T. Kadar, Aging, stress, and cognitive function, in: I.Z. Nagy, D. Harman, K. Kitani (Eds.), Pharmacology of Aging Processes, Ann. N.Y. Acad. Sci., New York, 717 (1994) 79-88.
12. [12] A. Levy, S. Dachir, I. Arbel, G.H. Beagley, T. Kadar, Deleterious consequences of corticosteroid exposure: possible therapeutic neuro-protection, in: A. Levy, E. Grauer, D. Ben-Nathan, R. DeKloet (Eds.), New Frontiers in Stress Research: Modulation of Brain Function, Harwood Academic Publishers, Amsterdam, (in press) pp. 105-116.
13. [13] A.H. Mohammed, Effects of cholinesterase ion learning and memory in rats: a brief review with special reference to THA, Acta Neurol. Scand. 149 (S) (1993) 13-15.
14. [14] J. Morris, P. Cyrus, J. Orazem, J. Mas, F. Bieber, B. Gulanski, Metrifonate: Potential therapy for Alzheimer's, in: Proceedings of the 49th Annual Meeting of the Am. A. of Ne., Boston, MA, April 12-19 (1997).
15. [15] I. Nordgren, B. Homstedt, Metrifonate: a review, in: E. Giacobini, R.E. Becker (Eds.), Current Research in Alzheimer Therapy, Taylor and Francis, New York, (1988) pp. 281-288.
16. [16] P. Riekkinen Jr., B. Schmidt, R. Stefanski, J. Kuitunen, M. Riekkinen, Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial septum-lesioned and aged rats, Eur. J. Pharmacol. 309 (1996) 121-130.
17. [17] P. Riekkinen Jr., B. Schmidt, M. Riekkinen, Behavioral characterization of metrifonate-improved acquisition of spatial information in medial septum-lessioned rats, Eur. J. Pharmacol. 323 (1997) 11-19.
18. [18] R.F. Ritzmann, A. Kling, C.L. Melchior, A.J. Glasky, Effect of age and strain on working memory in mice as measured in a win-shift paradigm, Pharmacol. Biochem. Behav. 44 (1993) 805-807.
19. [19] C. Scali, M.G. Giovannini, L. Bartolini, C. Prosperi, V. Hinz, B. Schmidt, G. Pepeu, Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats, Eur. J. Pharmacol. 325 (1997) 173-180.
20. [20] B.H. Schmidt, V.C. Hinz, A. Blokland, F.-J. van der Staay, R.J. Fanelli, Preclinical pharmacology of metrifonate: a promise for Alzheimer therapy, in: R.E. Becker, E. Giacobini, P. Robert (Eds.), Alzheimer Disease: From Molecular Biology to Therapy, Birkhauser, Boston, MA, 1996, pp. 217-221.
21. [21] B.H. Schmidt, V.C. Hinz, F.J. van der Staay, Cognition enhancement by metrifonate: evidence from animal studies, in: K. Iqbal, B. Winblad, T. Nishimura, M. Takeda, H.M. Wisniewski (Eds.), Alzheimer's Disease: From Molecular Biology to Therapy, Wiley, Chichester, 1997, pp. 781-786.
22. [22] T. Schuurman, Effects of calcium antagonists on memory and sensorimotor functions of aged animals, Neurosci. Res. Comm. 13 (S1) (1993) S59-S60.
23. [23] F.J. Van der Staay, V.C. Hinz, B.H. Schmidt, Effects of metrifonate on escape and avoidance learning in young and aged rats, Behav. Pharmacol. 7 (1996) 56-64.
24. [24] F.J. Van der Staay, V.C. Hinz, B.H. Schmidt, Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats, J. Pharm. Exp. Ther. 278 (1996) 697-708.
25. [25] M. Weinstock, The pharmacology of Alzheimer's disease based on the cholinergic hypothesis: an update, Neurodegeneration 4 (1995) 349-356.